Summary: Major Depressive Disorder (MDD) varies widely between people, and standard first-line treatments such as selective serotonin reuptake inhibitors (SSRIs) fail to adequately help a large proportion of patients. A recent study demonstrates a precision psychiatry approach using real-time fMRI neurofeedback to target the specific brain circuit that drives rumination, producing measurable reductions in depressive … Read more

Summary: Researchers have identified a distinct brain signal that reliably precedes attention lapses in children. By detecting this “attention signature” in real time and applying brief, precisely timed interventions, the team was able to restore focus immediately. This discovery points to new, targeted ways to support children with attention-related challenges such as ADHD or conditions … Read more

Summary: Major Depressive Disorder (MDD) is a heterogeneous condition: symptoms differ widely between patients, and standard first-line treatments such as selective serotonin reuptake inhibitors (SSRIs) fail to help a substantial portion of people. A recent study used a precision psychiatry approach—real-time fMRI functional connectivity neurofeedback—to train individuals to alter the neural circuit linked to rumination, … Read more

Summary: Researchers have identified a specific brain signal that reliably appears just before attention lapses in children. Monitoring this neural “attention signature” in real time enabled targeted interventions that immediately restored focus, suggesting a new approach to supporting youth with attention challenges such as ADHD and epilepsy. This discovery points toward precision neuromodulation methods that … Read more

Summary: Researchers report that the APOE2 form of the apolipoprotein E gene helps preserve neuronal DNA and prevents neurons from entering a damaged, senescent state. This genomic protection offers a likely explanation for APOE2 carriers’ increased longevity and lower Alzheimer’s disease risk. A new study from the Buck Institute for Research on Aging, published in … Read more

Summary: Researchers have long noticed that people who carry the APOE2 form of the apolipoprotein E gene tend to live longer and have a lower incidence of Alzheimer’s disease, but the biological basis for that protection was unclear. A new study from the Buck Institute identifies a clear cellular mechanism: APOE2 preserves genomic integrity in … Read more

Summary: Researchers have developed a personalized DNA cancer vaccine that produced encouraging results in an early-stage clinical trial for glioblastoma, showing safety, broad immune activation, and signals of improved survival in patients with aggressive, unmethylated tumors. The vaccine, GNOS-PV01, was well tolerated and provoked robust immune responses. In a small phase 1 trial, the treatment … Read more

Summary: Researchers have identified a promising new target to slow the progression of Parkinson’s disease (PD). The study finds that glycoprotein nonmetastatic melanoma B (GPNMB) promotes the cell-to-cell spread of pathological alpha-synuclein, and that monoclonal antibodies that block GPNMB can interrupt this process in preclinical models, pointing toward a potential disease‑modifying therapy. Using monoclonal antibodies … Read more

Summary: Researchers have developed a personalized DNA cancer vaccine that produced encouraging results in an early-stage clinical trial for glioblastoma. The trial shows that the vaccine, GNOS-PV01, is safe, provokes broad tumor-specific immune responses, and appears to improve survival outcomes for patients with aggressive, unmethylated forms of this usually incurable brain cancer. Key Research Findings … Read more

Summary: Researchers have identified a promising target for slowing the progression of Parkinson’s disease (PD). The study shows that the protein GPNMB (glycoprotein nonmetastatic melanoma B) acts as a catalyst for the spread of toxic alpha-synuclein aggregates between neurons. Blocking GPNMB with monoclonal antibodies interrupted this damaging cycle in preclinical models, suggesting a potential route … Read more